Regulatory role of c-Met in insulin-like growth factor-I receptor–mediated migration and invasion of human pancreatic carcinoma cells
-
- Todd W. Bauer
- 1Surgical Oncology and Departments of
-
- Ray J. Somcio
- 2Cancer Biology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas
-
- Fan Fan
- 2Cancer Biology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas
-
- Wenbiao Liu
- 2Cancer Biology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas
-
- Marjorie Johnson
- 2Cancer Biology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas
-
- Donald P. Lesslie
- 2Cancer Biology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas
-
- Douglas B. Evans
- 1Surgical Oncology and Departments of
-
- Gary E. Gallick
- 2Cancer Biology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas
-
- Lee M. Ellis
- 1Surgical Oncology and Departments of
抄録
<jats:title>Abstract</jats:title> <jats:p>Pancreatic carcinoma cells overexpress the insulin-like growth factor-I (IGF-I) receptor (IGF-IR) and the hepatocyte growth factor (HGF) receptor, c-Met, which are both known to mediate tumor cell migration and invasion. We hypothesized that IGF-IR and c-Met cooperate to induce migration and invasion of human pancreatic carcinoma cells and that IGF-I-mediated migration and invasion depend on c-Met. Migration and invasion assays were done with the human pancreatic cancer cell line L3.6pl treated with PBS, IGF-I, HGF, or IGF-I plus HGF. To determine if c-Met is necessary for IGF-IR-mediated migration and invasion, c-Met was down-regulated in L3.6pl cells via adenoviral infection with a c-Met ribozyme before IGF-I treatment. IGF-I and HGF increased cell migration and invasion. Furthermore, IGF-I plus HGF had a greater than additive effect on cell migration and invasion compared with either growth factor alone. Down-regulation of c-Met nearly completely inhibited IGF-I-mediated migration and invasion. Our findings suggest that IGF-IR and c-Met cooperate to induce migration and invasion of human pancreatic carcinoma cells. Furthermore, c-Met is required for both HGF- and IGF-I-mediated migration and invasion. Elucidation of the signaling pathways that contribute to tumor progression and metastasis should provide a foundation for the development of targeted therapies for pancreatic carcinoma. [Mol Cancer Ther 2006;5(7):1676–82]</jats:p>
収録刊行物
-
- Molecular Cancer Therapeutics
-
Molecular Cancer Therapeutics 5 (7), 1676-1682, 2006-07-01
American Association for Cancer Research (AACR)
- Tweet
キーワード
詳細情報 詳細情報について
-
- CRID
- 1363107369872350976
-
- NII論文ID
- 30018702888
-
- ISSN
- 15388514
- 15357163
-
- データソース種別
-
- Crossref
- CiNii Articles